A five-year experience in endoscopic endonasal excision of juvenile nasopharyngeal angiofibroma
More details
Hide details
Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
Department of Otorhinolaryngology-Head and Neck Surgery, Sarawak General Hospital, Sarawak, Malaysia
Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Sarawak, Malaysia
Submission date: 2021-01-30
Final revision date: 2021-03-11
Acceptance date: 2021-03-11
Online publication date: 2021-08-24
Corresponding author
Siew Chung Cheah   

Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia.
Pol. Ann. Med. 2022;29(1):44-48
Juvenile nasopharyngeal angiofibroma (JNA) is a histological benign but locally aggressive vascular tumour which can invade the base of skull.

This is a retrospective study with the aim to examine the outcome of patients with JNA and endoscopic endonasal excision of tumour at a tertiary center in Malaysia.

Material and methods:
9 patients were identified from the medical record office from 2015 to 2019. We review the data on patient demographics, clinical presentations, laboratory investigations, intraoperative blood loss and duration of hospital stay.

Results and discussion:
8 patients were male, 1 was female. The average age of diagnosis was 15 (range 11 to 29) years. The commonest chief complaint was recurrent epistaxis, followed by nasal obstruction and nasal discharge. Three patients were at stage I, 4 patients at stage II, 1 patient at stage III and 1 patient at stage IV based on Fisch classification. All patients underwent primary endoscopic endonasal excision of tumour with no vascular, ophthalmological or neurological complication. Seven patients had preoperative embolization done. Average operation time was 137 minutes (range 60–360 minutes). Intraoperative blood lost varied from 500 mL to 1300 mL (mean 777.7 mL). All patients were discharged well with no recurrence.

The management of JNA can be challenging. The current shift in management favouring endoscopic endonasal excision of JNA reduces postoperative morbidity. It is possible to be applied on all stages of tumour with good success rate.

None declared.
None declared.
Mann WJ, Jecker P, Amedee RG. Juvenile Angiofibromas: Changing surgical concept over the last 20 years. Laryngoscope. 2004;114(2):291–293.
Lim LY, Mohamad I, Tang IP. Endoscopic excision of juvenile nasopharyngeal angiofibroma: A case series. Egypt J ENT All Sci. 2017;18(2):173–176.
Scholtz AW, Appernroth E, Kammen-Jolly K, Scholtz LU, Thumfart WF. Juvenile Nasopharyngeal Angiofibroma: Management and Therapy. Laryngoscope. 2001;111(4 Pt 1):681–687.
Pryor S, Moore EJ, Kasperbauer JL. Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope. 2005;115(7):1201–1206.
Tang IP, Shshinder S, Gopala KG, Narayanan P. Juvenile nasopharyngeal angiofibroma in a tertiary centre: Ten- year experience. Singapore Med J. 2009;50(3):261–264.
Gaillard AL, Anastácio VM, Piatto VB, Maniglia JV, Molina FD. A seven-year experience with patients with juvenile nasopharyngeal angiofibroma. Braz J Otorhinolaryngol. 2010;76(2):245–250.
Fisch U. The infratemporal fossa approach for nasopharyngeal tumours. Laryngoscope. 1983;93(1):36–44.
Benjamin E, Wong DK, Choa D. ‘Moffett’s’ solution: Areview of the evidence and scientific basis for the topical preparation of the nose. Clin Otolaryngol Alllied Sci. 2004;29:582–587.
Midilli R, Karci B, Akyildiz S. Juvenile nasopharyngeal angiofibroma: Analysis of 42 cases and important aspects of endoscopic approach. Int J Pediatr Otorhinolaryngol. 2009;73(3):401–408.
Hackman T, Snyderman CH, Carrau R, Vescan A, Kassam A. Juvenile nasopharyngeal angiofibroma: The expanded endonasal approach. Am J Rhinol Allergy. 2009;23(1):95–99.
Alimli AG, Ucar M, Oztunali C, et al. Juvenile nasopharyngeal angiofibroma: Magnetic resonance imaging findings. J Belg Soc Radiol. 2016;100(1):63.
Wormald PJ, Hasselt AV. Endoscopic removal of juvenile angiofibromas. Otolaryngol Head Neck Surg. 2003;129(6):684–691.
Eloy P, Watelet JB, Hatert AS, de Wispelaere J, Bertrand B. Endonasal endoscopic resection of juvenile nasopharyngeal angiofibroma. Rhinology. 2007;45(1):24–30.
McAfee WJ, Morris CG, Amdur RJ, Werning JW, Mendenhall WM. Definitive radiotherapy for juvenile nasopharyngeal angiofibroma. Am J Clin Oncol. 2006;29(2):168–170.
McCombe A, Lund VJ, Howard DJ. Recurrence in juvenile angiofibroma. Rhinology. 1990;28(2):97–102.
Harma RA. Nasopharyngeal angiofibroma. Acta Otolaryngol. 1958;49:1–76.
Itoo FA, Iqbal I, Chiesti LA. Juvenile nasopharyngeal angiofibroma; A tertiary hospital – based experience. Indian J Clin Prac. 2014;25(4):352–355.
Journals System - logo
Scroll to top